NEUR30080 L16 DC exocytosis pt2

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/37

flashcard set

Earn XP

Description and Tags

go to YT video on BS

38 Terms

1
New cards

proteins involved in transmitter release

vesicle priming:

  • SNARE proteins:

    • synaptobrevin is bound to the vesicle membrane (vSNARE)

    • syntaxin and SNAP25 bound to the plasma memb (tSNARE)

  • synaptotagmin: Ca2+ dependence of NT release due to synaptotagmin binding Ca2+

  • !!!!!!!! finish this


2
New cards

vesicle priming

!!

3
New cards

fusion

!!

4
New cards

disassembling the SNARE complex

  • following fusion: SNARE complexes are disassembled

  • makes individual SNAREs available for subsequent fusion reactions

  • ATPase NSF and its adaptor protein soluble NSF attachment prot (SNAP) are responsible


5
New cards

disassembling SNARE image

knowt flashcard image
6
New cards

life cycle of the synaptic vesicle

  • however, it is likely refilling of vesicles happen much faster by utilising the kiss-and-run rather than full collapse method


7
New cards

life cycle of the synaptic vesicle image

knowt flashcard image
8
New cards

disruption of synaptic transmission

many poisionous agents and disease mechanisms exert their pathological effects through disruption of the synaptic transmission process

  • nerve agents: disrupt transmission at the NMJ

    • e.g. Novichok

  • pathological disorders of the NMJ:

    • myasthenia gravis

    • lambert eaton syndrome

    • tetanus toxin

    • botulinum toxin


9
New cards

Novichok

  • series of nerve agents devel. in Soviet union and russia 1971-1993

  • organophosphate AChE inhibitors

  • prevent the breakdown of ACh - enhanced ACh at NMJ

  • involuntary contraction of skeletal muscles

  • respiratory failure and cardiac arrest - death results from heart failure or suffocation as fluid secretions fill lungs


10
New cards

myasthenia gravis

autoimmune disease, ‘autoimmune synaptopathy’

identified 1930s

11
New cards

myasthenia gravis: symptoms

  • LT skeletal muscle weakness

  • symptoms increase during active periods, rest helps

  • common:

    • eye, eyelid, facial expression, chewing, talking, swallowing issues

  • progressive form:

    • impact muscles regulating respiration, neck and limb movement

  • ocular MG affects eye muscles only

  • rare genetic defect: congenital myasthenia


12
New cards

myasthenia gravis: common first signs image

knowt flashcard image
13
New cards

myasthenia gravis: important discoveries

synaptic transmission at NMJ is mediated by ACh

  • 1966: isolation of toxins from snake venom

  • alpha-bungarotoxin found to cause paralysis by irreversibly binding AChRs

  • alpha-bungarotoxin then used to isolate and purify AChRs from the electric organ of electric eel

MG symptoms could be reversed by inhibitors of AChE

  • AChRs injected into rabbits to generate Abs

  • unexpectedly, the Ab prod occurred with MG-like symptoms

most frequently presented in patients with other autoimmune disorders


14
New cards

myasthenia gravis: disease mechanism

  • prod of Abs - directed against the AChRs of NMJ

  • decreases availability of Rs for binding to ACh

  • inhibs muscle contraction

  • R loss - progresses MG


15
New cards

myasthenia gravis: structural changes

  • enlargement of syn cleft

  • junctional folding reduced


16
New cards

myasthenia gravis: structural change image

knowt flashcard image
17
New cards

myasthenia gravis: MoA

!!!!!!!!!!!!

18
New cards

myasthenia gravis: causes

  • autoimmune disease

  • bacterial infection: bacterial Ags may share epitopes with AChRs

  • viral infection: viral prot may include a peptide sequence similar to one in the AChR molecule (molecular mimicry)

  • thymomas: tumours derived from epithelial cells in thymus (usually benign) - 50% patients devel MG - express epitopes cross-reactive with AChRs and other skeletal muscle prots


19
New cards

myasthenia gravis: treatments

  • no known cure

  • AChE inhibitors treat symptoms

  • lifestyle changes: increase rest

  • immunosuppressant treamtnet: minimise immune response (Ab prod)

  • plasma exchange: removal of Abs from plasma to reduce excess

  • surgical intervention: e.g. thymectomy if thymoma is primary cause


20
New cards

lambert-eaton syndrome

lambert-eaton myasthenic syndrome (LEMS)

very rare autoimmune disorder

pre-synaptic focus

21
New cards

lambert-eaton syndrome: symptoms

muscle weakness in limbs

  • proximal arms and legs

  • greater impact to legs than arms

  • tingling in hands and feet

  • challenges climbing stairs and stand-to-sit movements

  • difficulty walking, reduced reflexes

  • weakness in respiratory muscles (advanced disease)
    temporary relief following exercise


22
New cards

lambert-eaton syndrome: pathology

  • pre-syn, targets NMJ

  • Abs to pre-syn Ca2+ channel - inhibits NT release


23
New cards

lambert-eaton syndrome: incidence

  • very rare: 2.8 cases per Million worldwide

  • approx. 60% assoc. with small cell lung carcinoma (SCLC)

  • sometimes symptoms detected prior to cancer diagnosis

  • cases unrelated to cancer, onset 40 yrs old


24
New cards

lambert-eaton syndrome: MoA

!!!!!

25
New cards

lambert-eaton syndrome: treatments

!!

26
New cards

tetanus

caused by neurotoxin Clostridium tetani

!!!!!!!!!!!!!!!!!

27
New cards

tetanus: symptoms

28
New cards

tetanus: MoA

29
New cards

tetanus: pathology

30
New cards

tetanus: MoA detail

31
New cards

tetanus: treatments

32
New cards

botulism

!!!!!!!!!!!!!!!!!

33
New cards

botulism: symptoms

34
New cards

botulism: MoA

35
New cards

botulism: image

36
New cards

botulism: treatment

37
New cards

botulinum toxin: therapeutic uses

38
New cards

botulinum toxin: other uses